Porcine Virus In Merck's RotaTeq Raises Questions Of Timing, Testing
This article was originally published in The Pink Sheet Daily
Executive Summary
Revealed on the eve of an advisory committee meeting about safety of GSK's rival vaccine Rotarix, finding suggests that FDA and industry have considerable work to do on viral testing techniques.